DSM, the largest manufacturer of high performance polyethylene (HPPE) fiber in
the world, today announces its decision to make another investment in a new
production line for Dyneema® fiber in Greenville, North Carolina (USA).
The Managing Board of Directors of DSM announces that Mr Henk van Dalen (53),
at present member of the DSM Managing Board, has decided to pursue his career
with TNT N.V. Henk van Dalen will be appointed Chief Financial Officer of the
Dutch express, logistics and postal services group with effect from 1 April
2006.
Royal DSM N.V. today announces the expansion of sizing production capacity in
China for Composite Resins. DSM Composite Resins AG will build a Sizing plant
on the existing DSM production site Xinghuo in Shanghai.
The Supervisory Board of DSM will propose to the Annual General Meeting on 29
March 2006 to appoint to the Managing Board with effect from the same date Mr
N. (Nico) Gerardu. He is to succeed Mr C.G. (Chris) Goppelsroeder.
The Managing Board of Directors of DSM announces the following appointments,
which have been made to replace business group directors who have reached
pensionable age and to fill the vacancies that have arisen due to other
appointments.
DSM will invest in the expansion of DSM Anti-Infectives’ production facilities
at Toansa (India). The investment will increase production of the
penicillin-related intermediate 6-APA and of active pharmaceutical ingredients
(APIs).
In Q3 2005 DSM posted a total Operating profit of EUR 220 million, which is up
44% from Q3 2004, due mainly to higher margins and lower fixed costs. Net
profit amounted to EUR 151 million, up 25% from Q3 2004 (EUR 121 million).
Dutch specialty chemicals company Royal DSM N.V. today acquired Syntech, a
producer and marketer of coating resins. Syntech has annual sales of around
USD 30 million, generated with a broad portfolio of coating resins.
The Innovation Centre will be managed by a newly created position of a Chief
Innovation Officer. The DSM Managing Board of Directors has appointed Mr Dr.
Rob van Leen (48), at present Business Group Director of the DSM Food
Specialties business group, to be the company’s Chief Innovation Officer.
DSM will today announce its new strategy program for the next five years. The
strategy will build on the strong foundation of the current Vision 2005
program through which a successful shift of DSM’s portfolio to specialty life
science and performance material products and more stable and higher earnings
were realized.
DSM and Lion Chemical Capital LLC today announce the agreement on the sale of
the DSM business unit SBR (styrene-butadiene rubber) to Lion Chemical Capital
LLC.
In the Dow Jones Sustainability World Index published yesterday, DSM once
again tops the list for the Chemical Industry sector. This is the second year
in a row that DSM has been named the worldwide sustainability leader in the
chemical industry.
DSM, the world-leading supplier of life science and nutritional products,
performance materials and industrial chemicals, today opened its first
Research & Development (R&D) Center in China. The center is located in
Shanghai.
On 5 September 2005 DSM will split its shares on a two-for-one basis (two
shares for one old share). This morning’s general meeting of shareholders
passed a resolution to this effect. The reason for the split is the relative
price level of the DSM share on the stock exchange (Euronext AEX).
In the second quarter of 2005 DSM posted a total Operating profit of EUR 217
million, up 43% from the second quarter of 2004, due in particular to higher
margins, lower costs and the contribution from DSM NeoResins (acquired in
February 2005).
DSM today announced that it has agreed to sell its 50% share interest in South
African yeast products manufacturer Rymco to its joint venture partner Daniel
Mills & Sons.
DSM and Dutch investment company Gilde Investment Management (Gilde) announce
that they signed and closed the sale of DSM Bakery Ingredients to Gilde last
night.
Today, DSM Nutritional Products announced its strategy for the production of
vitamin C. DSM will concentrate its production of bulk vitamin C in Dalry
(Scotland, UK). As a consequence, DSM will close its plant for bulk ascorbic
acid (vitamin C) in Belvidere (NJ, USA).
DSM Venturing, the corporate venturing unit of Dutch chemical specialties
maker DSM, today announced that it has taken a share interest in ORYXE Energy
International, based in Irvine, California (USA).
DSM posted an Operating profit of EUR 188 million in the first quarter of
2005, up EUR 57 million from the first quarter of 2004. Net profit from
ordinary activities was EUR 131 million, an increase of 35% compared with Q1
2004.
The total number of accidents at DSM declined by more than 20 percent in 2004
compared with 2003. With regard to the environment, nine of the fourteen
targets that were set for 2006 have already been met.
DSM, Universiteit Maastricht (UM) and academic hospital Maastricht (azM) have
entered into a strategic agreement for joint research and development projects.
Today Royal DSM N.V. completed the acquisition of NeoResins, the coating
resins business of Avecia. The intention of this acquisition was announced on
14 December 2004.
Royal DSM N.V. announced that it has reached principal agreement with Shanghai
Pharmaceutical Group to acquire the equity interests in Roche (Shanghai)
Vitamins Limited.
DSM announced today that due to increasing demand, it will add capacity for
Dyneema® yarn, DSM's high-performance polyethylene (HPPE) fiber, and Dyneema®
UD (UniDirectional bullet resistant sheet) in Greenville, North Carolina
(U.S.).
